- Home
- KIRK vs ABVC Comparison
KIRK vs ABVC Comparison
Compare KIRK & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIRK
- ABVC
- Stock Information
- Founded
- KIRK 1966
- ABVC 2015
- Country
- KIRK United States
- ABVC United States
- Employees
- KIRK N/A
- ABVC N/A
- Industry
- KIRK Diversified Commercial Services
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- KIRK Miscellaneous
- ABVC Health Care
- Exchange
- KIRK Nasdaq
- ABVC Nasdaq
- Market Cap
- KIRK 20.2M
- ABVC 16.7M
- IPO Year
- KIRK 2002
- ABVC N/A
- Fundamental
- Price
- KIRK $1.26
- ABVC $0.88
- Analyst Decision
- KIRK Buy
- ABVC
- Analyst Count
- KIRK 2
- ABVC 0
- Target Price
- KIRK $4.50
- ABVC N/A
- AVG Volume (30 Days)
- KIRK 101.2K
- ABVC 648.3K
- Earning Date
- KIRK 06-05-2025
- ABVC 04-15-2025
- Dividend Yield
- KIRK N/A
- ABVC N/A
- EPS Growth
- KIRK N/A
- ABVC N/A
- EPS
- KIRK N/A
- ABVC N/A
- Revenue
- KIRK $458,411,000.00
- ABVC $509,588.00
- Revenue This Year
- KIRK N/A
- ABVC $735.18
- Revenue Next Year
- KIRK $0.37
- ABVC N/A
- P/E Ratio
- KIRK N/A
- ABVC N/A
- Revenue Growth
- KIRK N/A
- ABVC 234.31
- 52 Week Low
- KIRK $1.10
- ABVC $0.40
- 52 Week High
- KIRK $2.57
- ABVC $1.73
- Technical
- Relative Strength Index (RSI)
- KIRK 48.49
- ABVC 49.97
- Support Level
- KIRK $1.13
- ABVC $0.81
- Resistance Level
- KIRK $1.22
- ABVC $1.00
- Average True Range (ATR)
- KIRK 0.08
- ABVC 0.15
- MACD
- KIRK 0.01
- ABVC -0.02
- Stochastic Oscillator
- KIRK 57.50
- ABVC 19.17
About KIRK Kirkland's Inc. COMMONSTOCK
Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.